Thu, Jul 31, 2014, 1:06 PM EDT - U.S. Markets close in 2 hrs 54 mins

Recent

% | $
Click the to save as a favorite.

Pharmagen, Inc. Message Board

  • eagle.legal18@rocketmail.com eagle.legal18 Aug 30, 2012 5:54 PM Flag

    ***Signs of Fed Investigation***

    If you want to see a sign of a Federal investigation, glance at the NSRS message board or the DCGD board (formerly NCDL). Notice that both boards contained evidence and both boards are now defunct. That's a sign that Jay Fung is getting slammed by the Feds.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • These companies never get investigated unless some important has lost money and even then class action suits only line the pockets of attorney's. So nothing will be done.

    • tom_stocks@ymail.com tom_stocks Aug 31, 2012 8:58 AM Flag

      Hi - Could the be under investigation? Sure..But the evidence you just presented as a basis for that point of view is maybe the stupidest thing I have read in a while. I knew if I checked out this MB I would find idiots! lol

      The board is defunct because they change the symbol when a company hasn't reported on time and the "E" is added. When they get in compliance (if), the "E" is dropped. When the E is added they get a new message board to coincide with the new symbol. When the E is dropped it takes a few days to a week to get the message board back up as if it was a new trading security.

      • 2 Replies to tom_stocks
      • And ANOTHER aricle includes (an older one) that of course one can't link to here, but try and figure it out - or run a search with something like "FINRA investigates Sunpeaks Ventures"

        Why? As it turns out, the Financial Industry Regulatory Authority (FINRA) had called SNPK to inform the company that it had "commenced … an inquiry" of its own.

        The stock, which had touched an intraday high of 68 cents before that jarring news, crashed to 29 cents, as jittery players bailed. Thanks to a sudden wave of buying power just before the close, however, SNPK handily recovered to end that volatile trading session on a strong note at 50 cents a share.

        For his part, SNPK Chief Executive Officer Mackie Barch automatically assured investors that, as the only insider who owns the stock, he still held all of his own shares. Barch instead blamed "persons unknown to current management" for the curious trading activity that had set off the alarm. In a further effort to calm frazzled nerves, SNPK then followed up with a special Saturday press release that officially identified former all-star NBA player Paul Silas as the spokesman for its expensive vitamin.

        APS soon came to the rescue as well. In a bold message to its followers, APS claimed that FINRA simply wanted to "make sure everything is fine over there, and it definitely seems to be fine" after news of the inquiry. By the following week, the crisis had blown over, and the stock resumed its climb. Some traders, besotted with ASP and its apparent invincibility, even viewed the recent setback as part of a grand plan.

        "The FINRA investigation, picture of SNPK HQ, sell-off 4/30/2012 were all moves in a game like chess," one investor cheerfully proclaimed. And "APS is the chess master. This stock is going to shock people with the PPS it will reach."

 
PHRX
0.0055+0.0012(+27.91%)12:47 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.